Key result
High-dose esmolol cuts cardiac output ~33% without altering intrathoracic blood volume.
Why the study?
Concerns exist regarding mathematical coupling between cardiac output and intrathoracic blood volume measurements using thermodilution methods.
Does high-dose esmolol-induced variation in cardiac output influence thermodilution measurements of intrathoracic blood volume in patients undergoing MIDCAB surgery?
Does high-dose esmolol-induced variation in cardiac output influence thermodilution measurements of intrathoracic blood volume in patients undergoing MIDCAB surgery?
Absolute Event Rate: 860% vs 876%
Changes in cardiac output do not mathematically couple with or influence thermodilution measurements of intrathoracic blood volume, validating its use as a preload indicator independent of CO variations.
ITBV unchanged despite 33% CO drop from esmolol; supports independence from coupling but leaves open broader validation.
BACKGROUND: Measurements of intrathoracic blood volume (ITBV) provide volumetric information about cardiac preload and are used to investigate the cause of alterations in cardiac output (CO). On the other hand, CO is required to calculate ITBV. Thus, concerns have been raised with respect to a mathematical coupling of data. The aim of this prospective, clinical study was to investigate whether a variation in CO induced by high-dose beta-blockade influences thermodilution measurements of ITBV in the absence of changes in intravascular volume in patients undergoing minimally invasive coronary artery bypass grafting. METHODS: Sixteen patients undergoing elective minimally invasive direct coronay artery bypass (MIDCAB) surgery were studied. Transpulmonary thermodilution measurements of ITBV and CO were simultaneously performed before bypass grafting, during beta-blockade induced by high-dose esmolol and at the end of surgery. RESULTS: During esmolol administration, CO significantly decreased by 33%, whereas ITBV remained unchanged compared to control values (876+/-46 ml m-2 during control versus 860+/-61 ml m-2 during esmolol administration). After the end of esmolol administration, CO significantly increased by 79%. Again, ITBV remained virtually unchanged (860+/-61 ml m-2 during esmolol administration versus 911+/-38 ml m-2 after esmolol administration). CONCLUSIONS: The results of the present study demonstrate that substantial alterations in CO as a consequence of high-dose esmolol infusion are not associated with changes in ITBV. Because haemodynamic changes were induced by factors other than variation of preload, these findings suggest that changes in cardiac output do not influence thermodilution measurements of ITBV in this setting.
No takes yet. Share an insight, caveat, or question.
Bühre et al. (2001) studied Elective minimally invasive direct coronary artery bypass (MIDCAB) surgery (n=16). High-dose esmolol vs. Baseline/control (before and after esmolol administration) was evaluated on Intrathoracic blood volume (ITBV). High-dose esmolol administration decreased cardiac output by 33% but did not alter intrathoracic blood volume (860 vs 876 ml/m2), suggesting no mathematical coupling of the measurements.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: